Julia Boshuizen

1.6k citations
11 papers · 952 indexed · h-index 8
Topics
Cancer Immunotherapy and Biomarkers (5 papers)CAR-T cell therapy research (4 papers)Phagocytosis and Immune Regulation (3 papers)

In The Last Decade

Julia Boshuizen

10 papers receiving 940 citations

Peers

Julia Boshuizen
Comparison fields: 5 of 73
  • Oncology 625
  • Molecular Biology 582
  • Immunology 225
  • Cancer Research 112
  • Pulmonary and Respiratory Medicine 95
Replace Katja Harbst with:
Katja Harbst Sweden
Azin Sayad Canada
Martine H. van Miltenburg Netherlands
Melanie L. Bailey Canada
Tammie C. Yeh United States
Christopher J. Tape United Kingdom
Jessica Frankum United Kingdom
Fleur Weeber Netherlands
Bose Kochupurakkal United States
Stacey M. Bagby United States
Julia Boshuizen relative to Katja Harbst Sweden Katja Harbst's profile →
Citations per field
00.5×1.5×
Katja Harbst · 1×
Citations per year

Countries citing papers authored by Julia Boshuizen

Since Specialization
Citations

This map shows the geographic impact of Julia Boshuizen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Boshuizen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Boshuizen more than expected).

Fields of papers citing papers by Julia Boshuizen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Boshuizen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Boshuizen. The network helps show where Julia Boshuizen may publish in the future.

Co-authorship network of co-authors of Julia Boshuizen

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Boshuizen. A scholar is included among the top collaborators of Julia Boshuizen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Boshuizen. Julia Boshuizen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 34
2 3
3 48
4 66
5 135
6 13
7 164
8 110
9 1
10 378
11 0

About Julia Boshuizen

Julia Boshuizen is a scholar working on Oncology, Immunology and Safety, Risk, Reliability and Quality, having authored 11 papers that have together received 952 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (4 papers) and Phagocytosis and Immune Regulation (3 papers). The work is most often cited by research in Oncology (625 citations), Immunology (225 citations) and Molecular Biology (582 citations). Julia Boshuizen has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Daniel S. Peeper, Christopher J. Lord, Richard Elliott, Farah Rehman, Alan Ashworth, Ying Feng, Ilirjana Bajrami, Yuqiao Shen, Bing Wang and Leonard Post. Their work appears in journals such as Nature, Nature Medicine and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026